Related posts

Nervous markets await Nvidia
Investor Insights

This summary was created by AI, based on 3 opinions in the last 12 months.

Quipt Home Medical, symbol QIPT-X, has garnered mixed reviews from industry experts. The CEO is recognized for being a capable operator, yet the stock struggles to gain attention from investors despite respectable EBITDA figures driven by equipment depreciation. The overall growth narrative appears stagnant, prompting concerns about its long-term potential, especially in an environment where healthcare innovations are impacting traditional sectors. While some experts note that the company operates well within the aging healthcare demographic, they also emphasize potential headwinds, such as competition from weight loss drugs that might diminish respiratory care needs. Valuation remains low compared to historical standards, reflecting cautious investor sentiment amid ongoing scrutiny regarding advertising practices.

Consensus
Negative
Valuation
Undervalued
DON'T BUY

CEO is a really good operator, but stock just doesn't seem to get any love. Numbers have been OK, but not any really great growth. Looks good on EBITDA (due to equipment depreciation), but not on earnings. Takeout rumours always swirl but he won't buy on that basis alone, praying for a takout, if the fundamentals aren't there.

The trend of keeping people out of hospitals sounds good, but he's a numbers guy and it doesn't have the growth he wants.

HOLD

Extremely challenged, though business continues to do well. One headwind is weight loss drug success makes investors concerned that respiratory issues will go away. That won't happen. Advertising practices under scrutiny, and there could be a fine.

Numbers continue to grow. Valuation lower than historically.

PARTIAL BUY

Does not own shares right now. Valuation remains low compared to peers. Not expecting growth - but is a good company. Healthcare space good with aging demographics. 

WAIT

It is executing well and the stock is cheap. It is a bit out of favour with no near term catalyst for buying right now. It has a great management team and is in a good sector. The volume of machine rentals out to homes is increasing.

COMMENT

This used to be called Patient Home Monitoring at one point. It is very cheap, has been performing and executing acquisitions pretty consistently. The CEO and management have done very well. The small cap health care sector is quiet but due to Quipt's good value it could be a takeover candidate.

TOP PICK

Continues to execute really well both organically and by acquisition. Sold off recently on management missteps on financing. Very attractive valuation, about 1/2 that of peers. Too cheap with the growth rate. No dividend.

(Analysts’ price target is $14.35)
RISKY

The chart if forming a cup (not bad), but swings lately are troublesome. Not for the timid. Very choppy. Maybe trade this, but be careful; resistance at $9.

BUY ON WEAKNESS

Does not own shares at the moment.
Lots of tailwinds with aging population.
Strong growth from demand for healthcare.
Capital markets have punished stock price due to questionable equity financing. 
Pressure in stock price is creating a buying opportunity.

WATCH

Owns a small position, but wants to see better momentum before adding more. They did a raise of $7.85 a few months ago and shares have been weak since. Are digesting their latest acquisition and should rise higher.

BUY ON WEAKNESS

Low valuation for in-home medical services company.
Does not own shares in the company, but has owned in the past.
Looking into buying shares in the future.
Management team has done great job growing company.


BUY

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research. Company recently acquired (Great Elm). At $80M it is a sizeable deal, but adds $60M in revenue and $13M in EBITDA. Should be $2M in cost savings and it is accretive to cash flow. The market likes the deal. Good earnings growth is expected. Unlock Premium - Try 5i Free

TOP PICK
Trades at significant discount of 2 multiple points to peers. Grows organically and by acquisition. CPI increase to Medicare and Medicaid has delivered price increases. No dividend. (Analysts’ price target is $14.20)
Unspecified
The underlying business is doing well but the stock is way down. It has a fortified balance sheet, is growing organically`and by acquisition. They have set up a recent bank arrangement for this. It should move in line with its peers.
PAST TOP PICK

(A Top Pick Nov 19/21, Down 35%) Respiration industry (repository technology and machines). Business growing well. Revenue growing with profits. Trading at 50% of multiple compared to peers. Will continue to hold shares.

PAST TOP PICK
(A Top Pick Sep 02/21, Down 19%) It deals in home care products, e.g. oxygen, etc. It has been growing the business by 30% over the year but the stock price is down because it is a small cap company. A different market moves them substantially higher. A recent banking deal allows for more acquisitions. It is moving from a regional player to a national one. Next year a lot of catalysts could move it higher.
Showing 1 to 15 of 21 entries

Quipt Home Medical(QIPT-X) Rating

Ranking : 3 out of 5

Star iconStar iconStar iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 3

Stockchase rating for Quipt Home Medical is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Quipt Home Medical(QIPT-X) Frequently Asked Questions

What is Quipt Home Medical stock symbol?

Quipt Home Medical is a Canadian stock, trading under the symbol QIPT-X on the TSX Venture Exchange (QIPT-CV). It is usually referred to as TSXV:QIPT or QIPT-X

Is Quipt Home Medical a buy or a sell?

In the last year, 3 stock analysts published opinions about QIPT-X. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Quipt Home Medical.

Is Quipt Home Medical a good investment or a top pick?

Quipt Home Medical was recommended as a Top Pick by on . Read the latest stock experts ratings for Quipt Home Medical.

Why is Quipt Home Medical stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Quipt Home Medical worth watching?

3 stock analysts on Stockchase covered Quipt Home Medical In the last year. It is a trending stock that is worth watching.

What is Quipt Home Medical stock price?

On 2023-06-20, Quipt Home Medical (QIPT-X) stock closed at a price of $7.28.